CELLPHIRE THERAPEUTICS

Serial Number 88983991
Registration 6740124
700

Registration Progress

Application Filed
Nov 21, 2019
Under Examination
Sep 8, 2020
Approved for Publication
Jul 14, 2020
Published for Opposition
Jul 14, 2020
Registered
May 24, 2022

Trademark Image

CELLPHIRE THERAPEUTICS

Basic Information

Serial Number
88983991
Registration Number
6740124
Filing Date
November 21, 2019
Registration Date
May 24, 2022
Published for Opposition
July 14, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 24, 2022
Registration
Registered
Classes
001

Rights Holder

Cellphire, Inc.

03
Address
9430 Key West Ave.
Rockville, MD 20850

Ownership History

Cellphire, Inc.

Original Applicant
03
Rockville, MD

Cellphire, Inc.

Owner at Publication
03
Rockville, MD

Cellphire, Inc.

Original Registrant
03
Rockville, MD

Legal Representation

Attorney
Leesa N. Weiss

USPTO Deadlines

Next Deadline
1030 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-05-24)
Due Date
May 24, 2028
Grace Period Ends
November 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jul 26, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 26, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 26, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 26, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 26, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 25, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 24, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 16, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 15, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 22, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 19, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 19, 2022 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Mar 18, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 7, 2022 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Mar 7, 2022 IUAF S USE AMENDMENT FILED Loading...
Mar 7, 2022 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Mar 7, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 7, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 7, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 7, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 25, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 25, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 8, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 14, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 14, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 24, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 10, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 9, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 8, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 8, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 4, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 4, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 4, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 28, 2020 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
May 12, 2020 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Apr 23, 2020 ALIE A ASSIGNED TO LIE Loading...
Apr 17, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 17, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 17, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 17, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 26, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 25, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 30, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 29, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 25, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Cells for scientific, laboratory or medical research; diagnostic, testing, and detection kits comprising blood platelets and other blood components for scientific, laboratory or medical research; diagnostic reagents for clinical or medical laboratory use, namely, compositions containing blood platelets or other blood components
First Use Anywhere: Feb 18, 2022
First Use in Commerce: Feb 18, 2022

Additional Information

Design Mark
The mark consists of the stylized word "CELLPHIRE" above the stylized word "THERAPEUTICS". A cell design formed by two stylized curved bars appears above and below the letters "CELL".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"